Mahima Gulati, a board certified endocrinologist at UConn Health, who is part of a national GLP-1 task force at the American College of Lifestyle Medicine, said most insurance companies are not covering the drug
Incretin therapy: should adverse consequences have been anticipated
However, several hypothetical explanations might account for why some patients report leg discomfort during treatment
Start instantly with a short eligibility review, then learn whether GLP-1 care may fit your body and goals
Any UK prescriber considering its use must be aware that it would be supplied as an imported unlicensed medicine on a named-patient basis, with full prescriber responsibility
Choosing your syringe U-100 syringes read 100 units per mL, U-50 read 50 per mL, and U-40 read 40 per mL, so the same volume shows a different number of units on each